News
ZHCLF
0.110
NaN%
--
Weekly Report: what happened at ZHCLF last week (0908-0912)?
Weekly Report · 09/15/2025 12:08
Weekly Report: what happened at ZHCLF last week (0901-0905)?
Weekly Report · 09/08/2025 12:11
Weekly Report: what happened at ZHCLF last week (0825-0829)?
Weekly Report · 09/01/2025 12:04
Weekly Report: what happened at ZHCLF last week (0818-0822)?
Weekly Report · 08/25/2025 12:20
Weekly Report: what happened at ZHCLF last week (0811-0815)?
Weekly Report · 08/18/2025 12:08
Weekly Report: what happened at ZHCLF last week (0804-0808)?
Weekly Report · 08/11/2025 12:18
Weekly Report: what happened at ZHCLF last week (0728-0801)?
Weekly Report · 08/04/2025 12:22
Weekly Report: what happened at ZHCLF last week (0721-0725)?
Weekly Report · 07/28/2025 12:22
Weekly Report: what happened at ZHCLF last week (0714-0718)?
Weekly Report · 07/21/2025 12:09
Weekly Report: what happened at ZHCLF last week (0707-0711)?
Weekly Report · 07/14/2025 12:23
Weekly Report: what happened at ZHCLF last week (0630-0704)?
Weekly Report · 07/07/2025 12:09
Weekly Report: what happened at ZHCLF last week (0623-0627)?
Weekly Report · 06/30/2025 12:19
Weekly Report: what happened at ZHCLF last week (0616-0620)?
Weekly Report · 06/23/2025 12:08
Weekly Report: what happened at ZHCLF last week (0609-0613)?
Weekly Report · 06/16/2025 12:18
Weekly Report: what happened at ZHCLF last week (0602-0606)?
Weekly Report · 06/09/2025 12:20
Weekly Report: what happened at ZHCLF last week (0526-0530)?
Weekly Report · 06/02/2025 12:33
Weekly Report: what happened at ZHCLF last week (0519-0523)?
Weekly Report · 05/26/2025 12:31
Weekly Report: what happened at ZHCLF last week (0512-0516)?
Weekly Report · 05/19/2025 12:18
More
Webull provides a variety of real-time ZHCLF stock news. You can receive the latest news about Zenith Cap through multiple platforms. This information may help you make smarter investment decisions.
About ZHCLF
Zenith Capital Corp, is a Canada-based biotechnology investment company. The Company’s wholly owned subsidiary is Zenith Epigenetics Ltd. Zenith Epigenetics is a clinical stage biotechnology company is focused on the discovery and development of therapeutics for the treatment of cancer and other disorders with unmet medical need. The Company is focused on developing various combinations of Bromodomain and ExtraTerminal domain (BET) inhibitors with other targeted agents. Its lead product candidate ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) and Triple Negative Breast Cancer.